Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120794 · ClinicalTrials.gov registry record · NA
Threshold Suspend in Pediatrics at Home
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT02120794: Completed NA study, sponsored by Medtronic MiniMed.
NCT02120794 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 194 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02120794, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
The study objective is to demonstrate that home use of Threshold Suspend (TS) is not associated with glycemic deterioration in pediatric patients with type 1 diabetes, as measured by change in A1C.
Interventions
- DEVICE 530G Insulin pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120794
The ClinicalTrials.gov registry entry for NCT02120794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 530G Insulin pump is the first listed.
NCT02120794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02120794 about?
NCT02120794 is a clinical study titled "Threshold Suspend in Pediatrics at Home". The study objective is to demonstrate that home use of Threshold Suspend (TS) is not associated with glycemic deterioration in pediatric patients with type 1 diabetes, as measured by change in A1C.
What is the current status of trial NCT02120794?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2014-06. Estimated completion is 2017-06-16.
What interventions are being tested in trial NCT02120794?
The interventions under investigation include: 530G Insulin pump (DEVICE).
Who is sponsoring clinical trial NCT02120794?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.